Concepedia

Larry C. Wienkers

LC

Statistics

Publications

60

Citations

4K

H-Index

36

Active since

1992

Affiliations

Amgen (United States)(Current)

University of Washington

W.E. Upjohn Institute for Employment Research

Pfizer (United States)

Kalamazoo College

Larry C. Wienkers is an author at Amgen (United States) specializing in pharmacology, cytochrome p450 enzymes, and medicine.

Publications per year

1992–2022

60

Publications

60

Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9

Allan E. Rettie, Larry C. Wienkers, Frank J. Gonzalez et al. · Pharmacogenetics · 1994 · 493 citations

, , +10

Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1.

Evan P. Gallagher, Larry C. Wienkers, Patricia L. Stapleton et al. · PubMed · 1994 · 223 citations

, , +17

Effects of Interleukin-6 (IL-6) and an Anti-IL-6 Monoclonal Antibody on Drug-Metabolizing Enzymes in Human Hepatocyte Culture

Leslie J. Dickmann, Sonal Patel, Dan A. Rock et al. · Drug Metabolism and Disposition · 2011 · 190 citations

, , +16

Warfarin-fluconazole. II. A metabolically based drug interaction: in vivo studies.

D J Black, Kent L. Kunze, Larry C. Wienkers et al. · Drug Metabolism and Disposition · 1996 · 178 citations

, , +17

Warfarin-fluconazole. I. Inhibition of the human cytochrome P450-dependent metabolism of warfarin by fluconazole: in vitro studies.

Kent L. Kunze, Larry C. Wienkers, Kenneth E. Thummel et al. · Drug Metabolism and Disposition · 1996 · 159 citations

, , +17

1–5 of 60